Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19
- Conditions
- Covid19 Prevention
- Interventions
- Other: placeboBiological: Gam-COVID-Vac
- First Posted Date
- 2020-08-28
- Last Posted Date
- 2021-01-22
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 33758
- Registration Number
- NCT04530396
- Locations
- 🇷🇺
ARCHIMED V Clinic of new medical technologies limited liability company, Moscow, Russian Federation
🇷🇺Medsi Group of companies joint-stock company", Moscow, Russian Federation
🇷🇺State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 219, Moscow Healthcare Department, Moscow, Russian Federation
An Open Study of the Safety, Tolerability and Immunogenicity of "Gam-COVID-Vac Lyo" Vaccine Against COVID-19
- Conditions
- Preventive Immunization COVID-19
- Interventions
- Biological: Gam-COVID-Vac Lyo
- First Posted Date
- 2020-06-18
- Last Posted Date
- 2020-08-12
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 38
- Registration Number
- NCT04437875
- Locations
- 🇷🇺
Sechenov First Moscow State Medical University, Moscow, Russian Federation
An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19
- Conditions
- Preventive Immunization COVID-19
- Interventions
- Biological: Gam-COVID-Vac
- First Posted Date
- 2020-06-18
- Last Posted Date
- 2020-08-12
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 38
- Registration Number
- NCT04436471
- Locations
- 🇷🇺
Main military clinical hospital named after academician N. N. Burdenko, Moscow, Russian Federation
Study of Safety and Immunogenicity of BVRS-GamVac
- Conditions
- MERSMERS (Middle East Respiratory Syndrome)
- Interventions
- Biological: BVRS-GamVacOther: placebo
- First Posted Date
- 2019-10-17
- Last Posted Date
- 2021-01-14
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 162
- Registration Number
- NCT04130594
- Locations
- 🇷🇺
Research Institute of Influenza, Sankt-Peterburg, Russian Federation
Study of Safety and Immunogenicity of BVRS-GamVac-Combi
- Conditions
- MERSMERS (Middle East Respiratory Syndrome)
- Interventions
- Other: placebo
- First Posted Date
- 2019-10-16
- Last Posted Date
- 2021-01-14
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 268
- Registration Number
- NCT04128059
- Locations
- 🇷🇺
ECO-Safety, Sankt-Peterburg, Russian Federation
A Phase 1/2 Clinical Trial of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine
- Conditions
- Whooping Cough
- Interventions
- Biological: Vaccine GamLPVOther: Placebo
- First Posted Date
- 2019-07-29
- Last Posted Date
- 2019-07-31
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 50
- Registration Number
- NCT04036526
- Locations
- 🇷🇺
Infectious Disease Clinical Hospital No. 1 of the Moscow Healthcare Department, Moscow, Russian Federation
A Double-blind Randomized Placebo-controlled Study Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac
- Conditions
- Healthy Volunteers
- Interventions
- Other: PlaceboBiological: GamFluVac
- First Posted Date
- 2019-07-26
- Last Posted Date
- 2020-08-25
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 224
- Registration Number
- NCT04034290
- Locations
- 🇷🇺
Federal state budgetary institution " Main military clinical hospital named after academician N. N. Burdenko " of the Ministry of Defence of the Russian Federation, Moscow, Russian Federation
Phase II Clinical Trial of Safety and Immunogenicity of Recombinant Subunit Tuberculosis Vaccine GamTBvac
- Conditions
- Healthy
- Interventions
- Biological: placeboBiological: GamTBvac vaccine
- First Posted Date
- 2019-03-18
- Last Posted Date
- 2020-06-17
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 180
- Registration Number
- NCT03878004
- Locations
- 🇷🇺
"City polyclinic № 2 Of the Department of health of the city of Moscow", Выделите текст, чтобы посмотреть примеры, Moscow, Russian Federation
🇷🇺Sechenov University, Moscow, Russian Federation
The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac
- Conditions
- Influenza AInfluenza H5N1Influenza EpidemicInfluenza A Virus Infection
- Interventions
- Biological: GamFluVac
- First Posted Date
- 2018-08-29
- Last Posted Date
- 2019-03-15
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 36
- Registration Number
- NCT03651544
- Locations
- 🇷🇺
Federal state budgetary institution " Main military clinical hospital named after academician N. N. Burdenko " of the Ministry of Defence of the Russian Federation, Moscow, Russian Federation
Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa
- Conditions
- Pseudomonas AeruginosaPseudomonas InfectionsUrinary Tract InfectionsPatients With Complicated Urinary Tract Infections Caused by P. Aeruginosa
- Interventions
- Drug: Ftortiazinon (tablets 300 mg) 1/2 dose +placebo+ MaxipimDrug: Ftortiazinon (tablets 300 mg) full dose + MaxipimOther: placebo+Maxipim
- First Posted Date
- 2018-08-20
- Last Posted Date
- 2021-01-14
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 777
- Registration Number
- NCT03638830
- Locations
- 🇷🇺
Scientific and Research Center "Eco-Safety", Saint-Petersburg, Russian Federation
🇷🇺Baltic Medicine, Saint-Petersburg, Russian Federation
🇷🇺Road Clinical Hospital of Open Joint Stock Company "Russian Railways, Saint Petersburg, Russian Federation